Chong, S., & Comer, S. D. (2023). Comment on: Effects of selective dopamine D3 receptor partial agonist/antagonists on oxycodone self-administration and antinociception in monkeys. Neuropsychopharmacology, 48(12), 1703–1704. https://doi.org/10.1038/s41386-023-01726-w

Wexler, T. L., & Page‐Wilson, G. (2023). Dopamine agonists for the treatment of pituitary tumours: From ergot extracts to next generation therapies. British Journal of Clinical Pharmacology, 89(4), 1304–1317. Portico. https://doi.org/10.1111/bcp.15660